EQS-News
The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
- PGH explores AI and biotech investment opportunities.
- New radiopharmaceutical shows superior diagnostic potential.
- TPG acquisition negotiations may impact share transfers.
|
EQS-News: The Payments Group Holding GmbH & Co. KGaA / Key word(s): Investment +++ Press release +++ |
The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
- AI company-building spin-offs
- Disruptive, demonstrably clearly superior and proven diagnostic radiopharmaceutical
- Negotiations with The Payments Group
Frankfurt/Main, 13 December 2025 – The Payments Group Holding (PGH), a holding company based in Frankfurt am Main that was founded in 2012 and renamed in August 2024, identifies interesting new fields of business activity and, at the same time, very promising investment opportunities. These opportunities originate, on the one hand, from company building activities jointly operated with Softmax AI and, on the other hand, from the continued pursuit of the research and development work of a team of senior physicians and chemists who have developed a new, disruptive, demonstrably superior radiopharmaceutical that has already been successfully tested for more than three years, for much higher-resolution imaging in the diagnosis of certain common, serious diseases, to identify the best, most targeted therapy option. Comparable products currently in use, but clearly inferior to this new development are among the so-called blockbusters, a term used in the pharmaceutical industry to describe products generating annual revenues in the billions.
In the field of artificial intelligence, the spin-off Cognicare AI, emerging from the company-building activities operated jointly with Softmax AI, currently stands out in particular, offering already proven and strongly demanded applications for the growing elderly care sector. PGH also expects further comparable success stories and opportunities for consolidation in 2026.

